Mrs Claire Cochran
Trial Manager
Bsc Geography (Hons), MsC Public Health (Medicine)
|
|
Personal Details
|
||||||||
Jump to:
Biography
Claire Cochran joined the Unit in October 2006, and took up position as the trial manager on the MAPS (Men After Prostate Surgery) trial. MAPS is a £1.3 million project (Funded by NHS R&D Health Technology Assessment (HTA) Programme) to investigate incontinence in men who have had prostate surgery. MAPS aimed to explore whether physiotherapy can help men who have had these kinds of surgery.
Claire graduated from
In 2008 Claire began a new position in HSRU as the trial manger of EAGLE. EAGLE is an MRC funded international multi-centre pragmatic randomised controlled trial (RCT) to establish whether removal of the lens of the eye (lens extraction) for newly diagnosed Primary Angle Closure Glaucoma results in better patient reported health, vision, lower IOP and other outcomes compared with standard management.
^ top
Current Research
EAGLE is an international multi-centre pragmatic randomised controlled trial (RCT) to establish whether removal of the lens of the eye (lens extraction) for newly diagnosed Primary Angle Closure Glaucoma results in better patient reported health, vision, lower IOP and other outcomes compared with standard management.
The current standard care for PACG is a stepped approach of a combination of surgery (laser or incisional) and medical management. Initial surgery uses a laser to make a small hole in the iris (laser iridotomy [LI]) to open the drainage angle, and often eye drops are required as an adjunct to LI to further reduce the IOP. There are several types of drops used to lower IOP but prostaglandin and beta-blocker treatments are the most commonly used. If the drainage pathway is still closed after LI, alternative laser treatment whereby iris tissue is pulled away from the drainage angle, laser peripheral iridoplasty (LPI) is an option. If these first line treatments fail glaucoma filtration surgery (trabeculectomy) is then indicated. Trabeculectomy may fail to control the IOP, and in PACG complications are more likely (such as flat anterior chamber and malignant glaucoma) than for other types of glaucoma. These standard approaches to PACG management have been noted to have variable success.
^ top
Publications
The PURE publications system is currently unavailable. Please try again later.
‹ back
